Patents by Inventor Thanos Andreou

Thanos Andreou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220362412
    Abstract: A non-destructive and reversible process to deodorize Nannochloropsis algae is provided.
    Type: Application
    Filed: July 1, 2020
    Publication date: November 17, 2022
    Inventors: Theocharis V. KOFTIS, Efstratios NEOKOSMIDIS, Michael TERZIDIS, Theodoros PANAGIOTIDIS, Thanos ANDREOU, Elli VASTARDI, Foteini ATHANASIADOU
  • Patent number: 11198671
    Abstract: The present invention relates to a novel process for the preparation of Vortioxetine and a key intermediate thereof by employing a novel one-pot organo-pseudocatalytic C—H activation approach via hypervalent iodine chemistry.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: December 14, 2021
    Assignee: VIO AG PHARMACEUTICALS S.A.
    Inventors: Theocharis V. Koftis, Efstratios Neokosmidis, Thanos Andreou, Petros Gkizis, Alexandra Lithadioti
  • Publication number: 20210163407
    Abstract: The present invention relates to a novel process for the preparation of Vortioxetine and a key intermediate thereof by employing a novel one-pot organo-pseudocatalytic C—H activation approach via hypervalent iodine chemistry.
    Type: Application
    Filed: June 19, 2019
    Publication date: June 3, 2021
    Applicant: VIO AG PHARMACEUTICALS S.A.
    Inventors: THEOCHARIS V. KOFTIS, EFSTRATIOS NEOKOSMIDIS, THANOS ANDREOU, PETROS GKIZIS, ALEXANDRA LITHADIOTI
  • Patent number: 8575343
    Abstract: The present invention provides an improved process for the preparation of (E)-N-(4-(4-fluorophenyl)-6-isopropyl-5-(3-oxoprop-1-enyl)pyrimidin-2-yl)-N-methyl methanesulfon-amide, which is a useful intermediate for the preparation of (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxy hept-6-enoic acid, commonly known as Rosuvastatin.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: November 5, 2013
    Assignee: Pharmathen S.A.
    Inventors: Theoharis V. Koftis, Thanos Andreou, Aristotelis Menisiou, Efstratios Neokosmidis, Asteria Zitrou
  • Publication number: 20130066074
    Abstract: The present invention provides an improved process for the preparation of (E)-N-(4-(4-fluorophenyl)-6-isopropyl-5-(3-oxoprop-1-enyl)pyrimidin-2-yl)-N-methyl methanesulfon-amide, which is a useful intermediate for the preparation of (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxy hept-6-enoic acid, commonly known as Rosuvastatin.
    Type: Application
    Filed: June 7, 2010
    Publication date: March 14, 2013
    Applicant: PHARMATHEN S.A.
    Inventors: Theoharis V. Koftis, Thanos Andreou, Aristotelis Menisiou, Efstratios Neokosmidis, Asteria Zitrou